The Risks or Lack Thereof of Migraine Treatments in Vascular Disease

Premises Patients with migraine have a co‐morbidity with vascular diseases such as hypertension, coronary heart disease, and stroke. Problem This overview gives recommendations for the therapy of acute migraine attacks and for migraine prevention in patients with vascular diseases. In particular, the use of triptans in patients with vascular diseases is discussed. Potential Solutions Currently, there is a contraindication for the use of the triptans in patients with vascular disease, although there is no evidence that triptans increase the risk of heart attacks or stroke.